Drawing for RECONNECT

USPTO serial 86402717

RECONNECT

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SPARACINO, MARK V
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with RECONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jason R. Lee

JASON R. LEE MOLEAC PTE LTD11 BIOPOLIS WAY#09-08HELIOS, 138667

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations; dietetic and nutritional supplements; food supplements; health supplements; plant and animal extracts for medicinal, dietetic, nutritional and health purposes; preparations and supplements for treatment and alleviation of symptoms and causes of neurological disorders, including neurological disorders affecting the central nervous system, the peripheral nervous system and the autonomic nervous system preparations and supplements for treatment and alleviation of symptoms and causes of brain injury, like stroke, trauma and global ischemia, preparations and supplements for treatment and alleviation of symptoms and causes of nervous system trauma and traumatic injuries to the spinal cord and peripheral nerves; preparations and supplements for treatment and alleviation of symptoms and causes of neurodegenerative disorders; preparations and supplements for treatment and alleviation of symptoms and causes of stroke, and dementia (e.g. Alzheimer's disease, Parkinson's disease, senile dementia, Huntington's disease); preparations and supplements for stroke prevention, acute stroke treatment, post-stroke recovery at chronic stage preparations and supplements for diminishing the effects of stroke or neurodegeneration in subjects predisposed to or at risk of stroke or neurodegeneration; preparations and supplements for treatment and alleviation of symptoms and causes of motor disabilities, including hemiplegia and loss of sensation following a stroke; preparations and supplements for treatment and alleviation of symptoms and causes of cognitive decline and impairment, including loss of memory following a stroke; preparations and supplements for treatment and alleviation of symptoms and causes of speech disorders (aphasia) following a stroke; preparations and supplements for treatment and alleviation of symptoms and causes of psychiatric indications (e.g. depression, anxiety disorders, schizophrenia, bipolar) preparations and supplements for increasing neuronal outgrowth and proliferation preparations and supplements for neuroprotection (e.g. from stroke), neuroconditioning, and neuroplasticity preparations and supplements for cerebrovascular and cardiovascular diseases and disorders (including cardiovascular protection after a stroke)ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Aug 11, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 11, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 13, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2015DOCKASSIGNED TO EXAMINER—
Sep 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 25, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance